Braxia Scientific Corp. (BRAXF)
OTC: BRAXF
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jun 06, 2025, 10:51 AM
Braxia Scientific Income Statement
Financials in CAD. Fiscal
year is
April - March.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 2.21M | 2.21M | 2.07M | 1.88M | 1.73M | 1.57M | 1.5M | 1.49M | 1.36M | 1.33M | 1.19M | 1.01M | 762.01K | 475.17K | 226.13K |
Cost of Revenue | 3.26M | 4.28M | 5.18M | 5.3M | 4.75M | 4.86M | 4.82M | 4.77M | 4.07M | 2.8M | 1.6M | 962.22K | 676.26K | 411.21K | 165.77K |
Gross Profit | -1.05M | -2.08M | -3.11M | -3.41M | -3.02M | -3.29M | -3.32M | -3.28M | -2.71M | -1.47M | -414.33K | 46.16K | 85.76K | 63.96K | 60.36K |
Operating Income | -4.32M | -5.76M | -7.27M | -7.43M | -7M | -7.09M | -7.03M | -7.16M | -7.52M | -6.58M | -6.92M | -10.82M | -11.39M | -9.96M | -7.9M |
Interest Income | 3.17K | 315.34K | 637.32K | 637.32K | 635.86K | 324.68K | 3.78K | 3.78K | 4.9K | 4.21K | 3.13K | 3.27K | 438.00 | 134.00 | 134.00 |
Pretax Income | -9.77M | -11.04M | -13.12M | -13.3M | -12.39M | -12.72M | -12.08M | -12.18M | -7.52M | -6.55M | -6.89M | -88.58M | -89.13M | -87.73M | -85.68M |
Net Income | -9.64M | -10.9M | -12.98M | -13.14M | -12.29M | -12.65M | -12.01M | -12.13M | -7.92M | -6.94M | -7.28M | -88.95M | -89.13M | -87.74M | -85.69M |
Selling & General & Admin | 2.82M | 3.58M | 4.06M | 3.92M | 3.77M | 3.67M | 3.57M | 3.66M | 4.18M | 3.7M | 4.5M | 8.13M | 9.2M | 8.52M | 7.07M |
Research & Development | 28.86K | 105.93K | 100.17K | 98.35K | 205.26K | 130.89K | 138.28K | 192.57K | 511.97K | 1.09M | 1.52M | 1.98M | 1.6M | 1.02M | 578.83K |
Other Expenses | 419.59K | n/a | n/a | n/a | n/a | n/a | n/a | -24.4K | -118.58K | -118.88K | -118.88K | -94.48K | -304 | n/a | n/a |
Operating Expenses | 3.26M | 3.68M | 4.16M | 4.02M | 3.98M | 3.8M | 3.71M | 3.88M | 4.81M | 5.04M | 6.44M | 10.79M | 11.39M | 10.01M | 7.95M |
Interest Expense | 58.85K | 33.18K | 329.28K | 330.02K | 328.62K | 329.62K | 8.72K | 4.95K | 4.85K | 4.15K | 3.08K | 2.04K | 438.00 | 134.00 | 134.00 |
Selling & Marketing Expenses | 91.39K | 111.49K | 153.68K | 152.44K | 36.23K | 149.81K | 164.34K | 253K | 954.5K | 911.28K | 1.35M | 1.85M | 2.1M | 2.07M | 1.55M |
Cost & Expenses | 6.52M | 7.96M | 9.34M | 9.32M | 8.73M | 8.66M | 8.53M | 8.65M | 8.88M | 7.84M | 8.04M | 11.75M | 12.07M | 10.42M | 8.12M |
Income Tax Expense | -138.62K | -144.69K | -156.23K | -175.74K | -75.12K | -57.32K | -51.46K | -21.01K | 400.56K | 389.76K | 391.99K | 377.39K | -2.91K | -964 | -991 |
Shares Outstanding (Basic) | 263.75M | 263.71M | 263.71M | 263.71M | 240.72M | 225.61M | 198.58M | 170.26M | 168.58M | 168.41M | 169.04M | 177.29M | 177.29M | 177.29M | 107.51M |
Shares Outstanding (Diluted) | 263.71M | 263.71M | 263.71M | 263.71M | 240.72M | 225.61M | 198.58M | 170.26M | 168.58M | 168.41M | 169.04M | 177.29M | 177.29M | 177.29M | 107.51M |
EPS (Basic) | -0.04 | -0.04 | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 | -0.07 | -0.05 | -0.04 | -0.04 | -0.8 | -0.88 | -0.87 | -0.86 |
EPS (Diluted) | -0.04 | -0.04 | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 | -0.07 | -0.05 | -0.04 | -0.04 | -0.8 | -0.88 | -0.87 | -0.86 |
EBITDA | -3.85M | -5.27M | -6.69M | -6.88M | -6.61M | -6.89M | -7M | -7.16M | -7.51M | -6.54M | -6.88M | -10.76M | -11.33M | -9.93M | -7.88M |
EBIT | -9.73M | -11.27M | -13.04M | -13.21M | -12.26M | -12.36M | -12.05M | -12.17M | -7.91M | -6.93M | -7.28M | -88.95M | -89.14M | -87.74M | -85.69M |
Depreciation & Amortization | 365.45K | 481.51K | 590.6K | 565.88K | 410.26K | 225.99K | 48.29K | 23.17K | 21.98K | 19.43K | 20.61K | 19.8K | 17.57K | 17.48K | 11.57K |